Logo image of HILS

HILLSTREAM BIOPHARMA INC (HILS) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:HILS - US4327051011 - Common Stock

0.2305 USD
+0.01 (+2.76%)
Last: 9/22/2023, 8:03:56 PM
0.2308 USD
+0 (+0.13%)
After Hours: 9/22/2023, 8:03:56 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to HILS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.08. This target is 1670.07% above the current price.
HILS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about HILS.
In the previous month the buy percentage consensus was at a similar level.
HILS was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

HILS Historical Analyst RatingsHILS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 0.234.044.084.084.20 - 1,652.71% 1,670.07% 1,670.07% 1,722.13%

Related screens

HILS Current Analyst RatingHILS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-07-17 Dawson James Downgrade Buy -> Neutral

HILLSTREAM BIOPHARMA INC / HILS FAQ

What is the average price target for HILLSTREAM BIOPHARMA INC (HILS) stock?

6 analysts have analysed HILS and the average price target is 4.08 USD. This implies a price increase of 1670.07% is expected in the next year compared to the current price of 0.2305.


What is the consensus rating for HILS stock?

The consensus rating for HILLSTREAM BIOPHARMA INC (HILS) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.